$ZY News
Last published 4y ago
- 4y agoDNAZYGinkgo Bioworks Completes Acquisition of ZymergenPR NewswireBOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE:DNA), the leading horizontal platform for cell programming, and Zymergen (NASDAQ:ZY) announced that Ginkgo has completed its
- 4y agoDNAZYGinkgo to Acquire ZymergenPR NewswireAcquisition is expected to accelerate the development of Ginkgo's innovative horizontal synthetic biology platform Expect integration of Zymergen's complementary automation, software, and data science tools as well as biological assets to significantly
- 4y agoZYZymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery PlatformGlobeNewswireEMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen" or the "Company") today announced it has expanded its agreement with Octant to further scale their next-generation platform to develop breakthrough medicines. In May, Octan
- 4y agoZYZymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing ApplicationsGlobeNewswireEMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen" or the "Company") today announced an R&D supply agreement to provide Zymergen Z2TM polyimide powder to 3D4Makers for use in high performance 3D printing applications. 3D4Ma
- 4y agoZYZymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery PlatformGlobeNewswireEMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen" or the "Company"), today announced it has entered into an agreement with Octant for the sale of a modular automation system to scale Octant's next-generation platform to dev
- 4y agoILMNMRNASEERZYSenti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)GlobeNewswire- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business Combination Agreement with DYNS - - DYNS announces effect
- 4y agoZYZymergen Reports Preliminary First Quarter 2022 Financial ResultsGlobeNewswireEMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. ("Zymergen" or the "Company"), today reported preliminary financial results for the first quarter ended March 31, 2022. "Our mission at Zymergen is to partner w
- 4y agoZYZymergen Inc. (ZY) Q1 2022 Earnings Call TranscriptEarnings Call TranscriptsZY earnings call for the period ending March 31, 2022.
- 4y agoZYZymergen to Participate in the BofA Securities 2022 Healthcare ConferenceGlobeNewswireEMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen" or the "Company"), today announced the company will be participating in the upcoming BofA Securities 2022 Healthcare Conference held in Las Vegas, NV. Zymergen's manage
- 4y agoZYZymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022GlobeNewswireEMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen" or the "Company") today announced it will report preliminary financial results for the first quarter 2022 after market close on Thursday, May 12, 2022. The company's manag
- 4y agoZYZymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewswireEMERYVILLE, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. ("Zymergen" or the "Company"), today reported preliminary financial results for the fourth quarter and full year ended December 31, 2021. "Our strategy is co
- 4y agoZYZymergen Inc. (ZY) Q4 2021 Earnings Call TranscriptEarnings Call TranscriptsZY earnings call for the period ending December 31, 2021.
- 4y agoZYZymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022GlobeNewswireEMERYVILLE, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen" or the "Company") today announced it will report preliminary financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 22nd, 2022.
- 4y agoZYZymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further TestingGlobeNewswireEMERYVILLE, Calif., March 06, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) is pleased to announce early results from its work on infectious disease, discovering hundreds of potential novel hits against malaria, tuberculosis, and COVID-1
- 4y agoZYZymergen to Present at the 42nd Annual Cowen Healthcare ConferenceGlobeNewswireEMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen" or the "Company"), today announced the company will be participating in the upcoming 42nd Annual Cowen Virtual Healthcare Conference. Zymergen's management is scheduled
- 4y agoZYZymergen Debuts Automation Business and Shares Program Portfolio at 40th Annual JP Morgan Healthcare ConferenceGlobeNewswireSAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) today announced a new Automation business and updated portfolio, further refining the company's focus on high-value solutions where its proprietary platform can provi
- 4y agoZYZymergen Announces Emerging Drug Discovery Business Enabled by One of the World's Largest Metagenomics Databases and Proprietary Synthetic Biology PlatformGlobeNewswireSAN FRANCISCO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) announced a new drug discovery business based around their proprietary synthetic biology platform and what is believed to be the world's largest metagenomics database,
- 4y agoZYZymergen to Present at the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireEMERYVILLE, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen"or the "Company"), today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Virtual Healthcare Conference. Zymergen's management is sched
- 4y agoDYNSILMNMRNARHHBY+2Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene TherapiesGlobeNewswire- Business combination with Dynamics Special Purpose Corp. (NASDAQ:DYNS) is expected to provide more than $296 million in gross proceeds, over $153 million of which is fully committed in a common stock Private Investment in Public Equity ("PIPE") financi
- 5y agoZYZymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewswireEMERYVILLE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen" or the "Company"), a leading biofacturing company, today reported preliminary financial results for the third quarter ended September 30, 2021. Since the previous busine
- 5y agoZYZymergen Inc. (ZY) Q3 2021 Earnings Call TranscriptEarnings Call TranscriptsZY earnings call for the period ending September 30, 2021.
- 5y agoZYZymergen to Report Third Quarter 2021 Financial Results on November 3, 2021GlobeNewswireEMERYVILLE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (NASDAQ:ZY) today announced it will report financial results for the third quarter 2021 after market close on Wednesday, November 3rd, 2021. The company's management will host a confer
- 5y ago688-SZBAS-DEDOWZYSolugen is making chemicals from sugar, not petroleumCNBCInvestors poured more than $350 million into Solugen, a sustainable chemicals start-up.
- 5y agoZYZymergen Announces Executive Appointments, Strengthening Leadership Team in Key AreasPR NewswireEMERYVILLE, Calif., Aug. 5, 2021 /PRNewswire/ -- Zymergen Inc. (NASDAQ:ZY) today announced the appointments of Lincoln Germain as Chief Commercial Officer and Subodh Deshmukh as Chief Development Officer.
- 5y agoVRTXEXASTDOCZYZymergen Can Thank Cathie Wood for Its Head-Spinning TurnaroundBloomberg
- 5y agoAMPEGENIHIMXSSYS+1Thinking about buying stock in Ampio Pharmaceuticals, Stratasys, Zymergen, Himax Technologies, or Genius Sports?PR NewswireNEW YORK, Aug. 5, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMPE, SSYS, ZY, HIMX, and GENI. To
- 5y agoJPMILMNZYSoftBank-Backed Zymergen Craters to Record Low After CEO LeavesBloomberg
- 5y agoZYZYMERGEN INVESTIGATION: Block & Leviton Investigates Zymergen For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the FirmGlobeNewswireBOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Zymergen, Inc. (NASDAQ:ZY) for potential securities law violations. Investors who have lost money in their Zymergen investment should contact the firm to learn more about how
- 5y agoZYZYzymergenSynthetic biology company Zymergen plunges 68% after saying product revenue will be 'immaterial' in 2022, removing CEOCNBCThree months after its IPO, Zymergen is warning investors that revenue is much further out than expected.
- 5y agoZYZymergen Provides Business UpdateGlobeNewswireJay Flatley, Chairman of the Board, Appointed Acting CEO; Josh Hoffman to Step Down Conference Call to be Held at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time Today EMERYVILLE, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen
- 5y agoZYZymergen to Present at Goldman Sachs Annual Global Healthcare ConferenceGlobeNewswireEMERYVILLE, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming Goldman Sachs Annual Global Healthcare Virtual Conference. Zymergen's management is scheduled to pr
- 5y agoZYAccelerator Life Science Partners' Portfolio Company Lodo Therapeutics Acquired by Zymergen Inc.Business WireAccelerator Life Science Partners ("ALSP"), a leading early-stage life science accelerator and investment firm, today announced that its portfolio company, Lodo Therapeutics Corporation ("Lodo" or the "Company"), has been acquired by Zymergen Inc. (NASD
- 5y agoZYZymergen Reports Preliminary First Quarter 2021 Financial ResultsGlobeNewswireEMERYVILLE, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen"), one of the world's leading biofacturing companies, today reported preliminary financial results for the first quarter ended March 31, 2021. "I am so proud of our tea
- 5y agoZYZymergen to Present at UBS Global Healthcare Virtual ConferenceGlobeNewswireEMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming UBS Global Healthcare Virtual Conference. Zymergen's management is scheduled to present on Wedne
- 5y agoZYZymergen to Report First Quarter 2021 Financial Results on May 24, 2021GlobeNewswireEMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021. The company's management will host a conferenc
- 5y agoZYZymergen Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewswireEMERYVILLE, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen"), one of the world's foremost biofacturing companies, today announced the closing of its initial public offering of 18,549,500 shares of its common stock, including the fu
- 5y agoGSJPMZY‘Biofacturing’ Firm Zymergen Rises in Debut After Upsized IPOBloomberg
- 5y agoGSJPMZY‘Biofacturing’ Firm Zymergen Raises $500 Million in Expanded IPOBloomberg
- 5y agoZYZymergen Announces Pricing of Upsized Initial Public OfferingGlobeNewswireEMERYVILLE, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. ("Zymergen"), one of the world's foremost biofacturing companies, today announced the pricing of its initial public offering of 16,130,000 shares of its common stock at a public offer
- 5y agoZYZymergen Announces Launch of Initial Public OfferingGlobeNewswireEMERYVILLE, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced that it has launched the roadshow for the...